The Long-Term Safety of Budesonide for Patients With Chronic Rhinosinusitis

Recruiting

BudesonideThe Long-Term Safety of Budesonide for Patients With Chronic Rhinosinusitis

Sponsor:

St. Paul's Hospital, Canada

Code:

NCT03584178

Conditions

Sinusitis

Eligibility Criteria

Sex: All

Age: 19 - 70+

Healthy Volunteers: Not accepted

Interventions

Budesonide via MAD device

Budesonide via intranasals Saline Irrigation

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-27. This information was provided to ClinicalTrials.gov by St. Paul's Hospital, Canada on 2019-09-20.